Cargando…
Blocking TGFβ via Inhibition of the αvβ6 Integrin: A Possible Therapy for Systemic Sclerosis Interstitial Lung Disease
Interstitial lung disease (ILD) is a commonly encountered complication of systemic sclerosis (SSc) and accounts for a significant proportion of SSc-associated morbidity and mortality. Its pathogenesis remains poorly understood, and therapies that treat SSc ILD are suboptimal, at best. SSc ILD pathog...
Autores principales: | Katsumoto, Tamiko R., Violette, Shelia M., Sheppard, Dean |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195527/ https://www.ncbi.nlm.nih.gov/pubmed/22013449 http://dx.doi.org/10.1155/2011/208219 |
Ejemplares similares
-
Inhibition of Integrin αvβ6 Activation of TGF‐β Attenuates Tendinopathy
por: Wang, Xiao, et al.
Publicado: (2022) -
TGFβ(1 )signaling via α(V)β(6 )integrin
por: Kracklauer, Martin P, et al.
Publicado: (2003) -
Inhibition of integrin α(V)β(6) changes fibril thickness of stromal collagen in experimental carcinomas
por: Olof Olsson, P., et al.
Publicado: (2018) -
Induced hepatic stellate cell integrin, α8β1, enhances cellular contractility and TGFβ activity in liver fibrosis
por: Nishimichi, Norihisa, et al.
Publicado: (2021) -
Integrin α(V)β(6)-mediated activation of latent TGF-β requires the latent TGF-β binding protein-1
por: Annes, Justin P., et al.
Publicado: (2004)